Prokidney PROK
NASDAQ PROK
$1.85 -0.14 (-7.04%)
At close: Sep 9, 2026 · 4:00 PM EDT

Prokidney (PROK) Depreciation & Amortization (CF) (2021 - 2026)

Prokidney's (PROK) quarterly Depreciation & Amortization (CF) came in at $1.4 million in Q2 2026, down 2.82% year-over-year from $1.5 million in Q2 2025, and down 12.61% quarter-over-quarter from $1.7 million in Q1 2026.

Analysis

Prokidney (PROK) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends

Prokidney (PROK) has reported Depreciation & Amortization (CF) for 6 consecutive years, with $1.4 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 2.82% year-over-year to $1.4 million in Q2 2026; TTM through Jun 2026 was $6.3 million, a 8.15% increase from a year earlier, with the FY2025 full-year figure at $6.6 million, up 21.04% from the prior year.
  • Depreciation & Amortization (CF) was $1.4 million for Q2 2026 at Prokidney, down from $1.7 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $1.8 million in Q4 2025 and troughed at $710000.0 in Q1 2022.
  • A 5-year average of $1.2 million and a median of $1.1 million in 2023 frame the typical range for Depreciation & Amortization (CF).
  • Across the five-year window, Depreciation & Amortization (CF) surged 54.67% in 2025 and declined 2.82% in 2026, its largest moves.
  • Over 5 years, Depreciation & Amortization (CF) stood at $791000.0 in 2022, then soared by 44.88% to $1.1 million in 2023, then jumped by 37.35% to $1.6 million in 2024, then increased by 16.71% to $1.8 million in 2025, then declined by 21.12% to $1.4 million in 2026.
  • The last three Depreciation & Amortization (CF) figures came in at $1.4 million (Q2 2026), $1.7 million (Q1 2026), and $1.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn -
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn - 4.28 Mn
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn 3.78 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn 4.00 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn 4.91 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn - 5.41 Mn
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn 1.10 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn 10.41 Mn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn 3.62 Mn
10 Prokidney 346.07 Mn 346.07 Mn - 1.45 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.45 Mn
Mar 31, 2026 1.66 Mn
Dec 31, 2025 1.84 Mn
Sep 30, 2025 1.40 Mn
Jun 30, 2025 1.49 Mn
Mar 31, 2025 1.60 Mn
Dec 31, 2024 1.57 Mn
Sep 30, 2024 1.20 Mn
Jun 30, 2024 964,000.00
Mar 31, 2024 1.10 Mn
Dec 31, 2023 1.15 Mn
Sep 30, 2023 1.01 Mn
Jun 30, 2023 870,000.00
Mar 31, 2023 832,000.00
Dec 31, 2022 791,000.00
Sep 30, 2022 783,000.00
Jun 30, 2022 752,000.00
Mar 31, 2022 710,000.00
Dec 31, 2021 587,000.00